Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Malignant gliomas can be converted to non‑proliferating glial cells by treatment with a combination of small molecules.

Oh J, Kim Y, Baek D, Ha Y.

Oncol Rep. 2019 Jan;41(1):361-368. doi: 10.3892/or.2018.6824. Epub 2018 Oct 25.

PMID:
30365111
2.

Regulation of cAMP and GSK3 signaling pathways contributes to the neuronal conversion of glioma.

Oh J, Kim Y, Che L, Kim JB, Chang GE, Cheong E, Kang SG, Ha Y.

PLoS One. 2017 Nov 21;12(11):e0178881. doi: 10.1371/journal.pone.0178881. eCollection 2017.

3.
4.

MicroRNA 335 is required for differentiation of malignant glioma cells induced by activation of cAMP/protein kinase A pathway.

Shu M, Zhou Y, Zhu W, Zhang H, Wu S, Chen J, Yan G.

Mol Pharmacol. 2012 Mar;81(3):292-8. doi: 10.1124/mol.111.076166. Epub 2011 Dec 15.

5.

Up-regulation of the cAMP/PKA pathway inhibits proliferation, induces differentiation, and leads to apoptosis in malignant gliomas.

Chen TC, Hinton DR, Zidovetzki R, Hofman FM.

Lab Invest. 1998 Feb;78(2):165-74. Review.

PMID:
9484714
6.

Targeting malignant gliomas with a glial fibrillary acidic protein (GFAP)-selective oncolytic adenovirus.

Horst Mt, Brouwer E, Verwijnen S, Rodijk M, de Jong M, Hoeben R, de Leeuw B, Smitt PS.

J Gene Med. 2007 Dec;9(12):1071-9.

PMID:
17902184
7.

Expression of vimentin and glial fibrillary acidic protein in ethylnitrosourea-induced rat gliomas and glioma cell lines.

Reifenberger G, Bilzer T, Seitz RJ, Wechsler W.

Acta Neuropathol. 1989;78(3):270-82.

PMID:
2475009
9.
10.

8-Cl-cAMP and tiazofurin affect vascular endothelial growth factor production and glial fibrillary acidic protein expression in human glioblastoma cells.

Drabek K, Pesić M, Piperski V, Ruzdijić S, Medić-Mijacević L, Pietrzkowski Z, Rakić L.

Anticancer Drugs. 2000 Oct;11(9):765-70.

PMID:
11129740
11.

Epigenetic regulation of glial fibrillary acidic protein by DNA methylation in human malignant gliomas.

Restrepo A, Smith CA, Agnihotri S, Shekarforoush M, Kongkham PN, Seol HJ, Northcott P, Rutka JT.

Neuro Oncol. 2011 Jan;13(1):42-50. doi: 10.1093/neuonc/noq145. Epub 2010 Nov 12.

12.

[The distribution of glial fibrillary acidic protein and protein S-100 in experimental brain tumors in rats].

Khalanskiĭ AS, Shevchenko GM, Berezin VA.

Zh Vopr Neirokhir Im N N Burdenko. 1991 Jan-Feb;(1):19-22. Russian.

PMID:
1649519
13.
14.
15.

Silencing mammalian target of rapamycin signaling by small interfering RNA enhances rapamycin-induced autophagy in malignant glioma cells.

Iwamaru A, Kondo Y, Iwado E, Aoki H, Fujiwara K, Yokoyama T, Mills GB, Kondo S.

Oncogene. 2007 Mar 22;26(13):1840-51. Epub 2006 Sep 25.

PMID:
17001313
16.

Analysis of glial fibrillary acidic protein gene methylation in human malignant gliomas.

Fukuyama K, Matsuzawa K, Hubbard SL, Dirks PB, Murakami M, Rutka JT.

Anticancer Res. 1996 May-Jun;16(3A):1251-7.

PMID:
8702246
17.

Products of cells cultured from gliomas. VII. Extracellular matrix proteins of gliomas which contain glial fibrillary acidic protein.

McKeever PE, Fligiel SE, Varani J, Castle RL, Hood TW.

Lab Invest. 1989 Feb;60(2):286-95.

PMID:
2464718
18.

Immunohistochemical expression of glial fibrillary acidic protein and CAM5.2 in glial tumors and their role in differentiating glial tumors from metastatic tumors of central nervous system.

Goyal R, Mathur SK, Gupta S, Goyal R, Kumar S, Batra A, Hasija S, Sen R.

J Neurosci Rural Pract. 2015 Oct-Dec;6(4):499-503. doi: 10.4103/0976-3147.168426.

19.

In vitro identification and functional characterization of glial precursor cells in human gliomas.

Colin C, Baeza N, Tong S, Bouvier C, Quilichini B, Durbec P, Figarella-Branger D.

Neuropathol Appl Neurobiol. 2006 Apr;32(2):189-202.

PMID:
16599947
20.

Evidence for central nervous system glial cell plasticity in phenylketonuria.

Dyer CA, Kendler A, Philibotte T, Gardiner P, Cruz J, Levy HL.

J Neuropathol Exp Neurol. 1996 Jul;55(7):795-814.

PMID:
8965095

Supplemental Content

Support Center